Joseph S. Ladd - Academia.edu (original) (raw)
Uploads
Papers by Joseph S. Ladd
Pharmacy Today, Mar 1, 2019
Pharmacy Today, Apr 1, 2017
Mortality risk lower in vancomycin vs. metronidazole for CDI, but both agents have their strength... more Mortality risk lower in vancomycin vs. metronidazole for CDI, but both agents have their strengths I n its February 2017 issue, JAMA published the largest study to date comparing metronidazole and vancomycin for treatment of Clostridium difficile infection (CDI) in a real-world setting. This retrospective, propensitymatched cohort by Stevens et al. evaluated the risk of recurrence and all-cause 30-day mortality in 10,137 patients receiving metronidazole or vancomycin for treatment of mild to moderate and severe CDI in the U.S. Department of Veterans Affairs health care system from January 1, 2005, to December 31, 2012. While data showed that recurrence rates were similar between groups, risk of mortality was significantly reduced among those treated with vancomycin.
Pharmacy Today, Sep 1, 2018
Pharmacy Today, Jul 1, 2017
Pharmacy Today, 2016
Ticagrelor may be an option for patients who cannot use aspirin joseph ladd A fter an acute cereb... more Ticagrelor may be an option for patients who cannot use aspirin joseph ladd A fter an acute cerebrovascular event, many patients rely on clinical judgment to select a secondary prophylaxis regimen. While aspirin therapy is common in this setting, it has its limitations, and the availability of newer antiplatelet agents provides other options.
Pharmacy Today, 2018
Enhancing glycemic management for older adults A cross-sectional analysis published recently in t... more Enhancing glycemic management for older adults A cross-sectional analysis published recently in the Journal of the American Geriatrics Society found that one-quarter of older adults with type 2 diabetes were tightly controlled and receiving glucose-lowering medications with high risk for hypoglycemia. 1
Pharmacy Today, Dec 1, 2017
Pharmacy Today, Nov 1, 2017
Pharmacy Today, Dec 1, 2017
Pharmacy Today, 2018
Three-in-one low-dose tablet shows promise for optimum BP control A triple half-dose combination ... more Three-in-one low-dose tablet shows promise for optimum BP control A triple half-dose combination therapy can increase the proportion of patients achieving target blood pressure (BP) goals compared with usual care, according to a recent JAMA study. 1
Pharmacy Today, Nov 1, 2017
Pharmacy Today, Feb 1, 2019
Pharmacy Today, Feb 1, 2019
Pharmacy Today, Mar 1, 2019
Pharmacy Today, Apr 1, 2017
Mortality risk lower in vancomycin vs. metronidazole for CDI, but both agents have their strength... more Mortality risk lower in vancomycin vs. metronidazole for CDI, but both agents have their strengths I n its February 2017 issue, JAMA published the largest study to date comparing metronidazole and vancomycin for treatment of Clostridium difficile infection (CDI) in a real-world setting. This retrospective, propensitymatched cohort by Stevens et al. evaluated the risk of recurrence and all-cause 30-day mortality in 10,137 patients receiving metronidazole or vancomycin for treatment of mild to moderate and severe CDI in the U.S. Department of Veterans Affairs health care system from January 1, 2005, to December 31, 2012. While data showed that recurrence rates were similar between groups, risk of mortality was significantly reduced among those treated with vancomycin.
Pharmacy Today, Sep 1, 2018
Pharmacy Today, Jul 1, 2017
Pharmacy Today, 2016
Ticagrelor may be an option for patients who cannot use aspirin joseph ladd A fter an acute cereb... more Ticagrelor may be an option for patients who cannot use aspirin joseph ladd A fter an acute cerebrovascular event, many patients rely on clinical judgment to select a secondary prophylaxis regimen. While aspirin therapy is common in this setting, it has its limitations, and the availability of newer antiplatelet agents provides other options.
Pharmacy Today, 2018
Enhancing glycemic management for older adults A cross-sectional analysis published recently in t... more Enhancing glycemic management for older adults A cross-sectional analysis published recently in the Journal of the American Geriatrics Society found that one-quarter of older adults with type 2 diabetes were tightly controlled and receiving glucose-lowering medications with high risk for hypoglycemia. 1
Pharmacy Today, Dec 1, 2017
Pharmacy Today, Nov 1, 2017
Pharmacy Today, Dec 1, 2017
Pharmacy Today, 2018
Three-in-one low-dose tablet shows promise for optimum BP control A triple half-dose combination ... more Three-in-one low-dose tablet shows promise for optimum BP control A triple half-dose combination therapy can increase the proportion of patients achieving target blood pressure (BP) goals compared with usual care, according to a recent JAMA study. 1
Pharmacy Today, Nov 1, 2017
Pharmacy Today, Feb 1, 2019
Pharmacy Today, Feb 1, 2019